Drugs / DNS-3379
last change Dec 2017 re-read 3 minutes ago

DNS-3379

Developed for
ischemic stroke
Investigated by
Dart NeuroScience, LLC

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03254160 Nov → Dec 2017 ischemic stroke Dart NeuroScience, LLC Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DNS-3379 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03254160 ↗